Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis

Ismet H. Bajraktari; Sylejman Rexhepi; Idriz Berisha; Ali Lahu; Avni Kryeziu; Bastri Durmishi; Halit Bajraktari; Elton Bahtiri

doi:10.3889/oamjms.2017.146

Authors

Ismet H. Bajraktari Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Sylejman Rexhepi Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Idriz Berisha Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Ali Lahu Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Avni Kryeziu Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Bastri Durmishi Clinic of Rheumatology, University Clinical Center of Kosovo, Prishtina, Kosovo
Halit Bajraktari Emergency Center, University Clinical Center of Kosovo, Prishtina, Kosovo
Elton Bahtiri Clinic of Endocrinology, University Clinical Center of Kosovo, Prishtina, Kosovo; Department of Pharmacology, Faculty of Medicine, University of Prishtina, Kosovo

DOI:

https://doi.org/10.3889/oamjms.2017.146

Keywords:

Early Rheumatoid Arthritis, Hypertension, CRP, ESR, Anti CCP, DAS-28

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that worsens during the course of the disease and can cause disability. Early RA refers to the onset of symptoms within the past 3 months. In RA, increased levels of mediators of inflammation may cause arterial stiffness consequently leading to arterial hypertension.

AIM: The aim of this cross-sectional study was to assess the prevalence of asymptomatic arterial hypertension in early RA patients as well as the correlation with parameters of inflammation.

METHODS: One hundred and seventy-nine early RA patients diagnosed in agreement with ACR/EULAR (American College of Rheumatology/ European League against Rheumatism) 2010 criteria were consecutively included in the study. CRP (C-reactive protein) and anti CCP (Antibodies to cyclic citrullinated peptides) serum levels, WBC (white blood cells) count and ESR (Erythrocyte sedimentation rate), likewise DAS-28 (28-joint disease activity score) was determined in all included patients. Parametric tests were used to compare the characteristics of the groups and to test the correlation of the variables.

RESULTS: Statistical data analysis revealed that a majority of the patients were females (n = 141; 78.7%); the mean age at RA onset was 49.13 Â± 12.13 years. Overall prevalence of hypertension was 44.13 % (n = 79). In comparison with the normotensive patients, the hypertensive patients were older and had significantly higher values of CRP, ESR, anti-CCP and DAS-28. A highly significant positive correlation between all the study parameters and systolic and diastolic blood pressure was observed.

CONCLUSION: Presence of significantly higher values of CRP, ESR, anti-CCP and DAS-28 in hypertensive patients indicate that inflammation is associated with an increased risk of hypertension. In this context, early screening for arterial hypertension and adequate therapeutic measures should be considered in early RA patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Verma MK, Sobha K. Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects. Inflamm Res. 2015;64(9):647-59. https://doi.org/10.1007/s00011-015-0843-8 PMid:26149692

Combe B. Progression in early rheumatoid arthritis.Best Pract Res Clin Rheumatol. 2009;23(1):59-69. https://doi.org/10.1016/j.berh.2008.11.006 PMid:19233046

Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford). 2007;46(2):342-9. https://doi.org/10.1093/rheumatology/kel237 PMid:16899498

Demoruelle MK, Deane KD. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep. 2012;14(5):472-80. https://doi.org/10.1007/s11926-012-0275-1 PMid:22773387 PMCid:PMC3616381

Solomon DH, Reed GW, Kremer JM, Curtis JR, Farkouh ME, Harrold LR, et al. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015;67(6):1449-55. https://doi.org/10.1002/art.39098 PMid:25776112 PMCid:PMC4446181

Pieringer H, Pichler M. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM. 2011;104(1):13-26. https://doi.org/10.1093/qjmed/hcq203 PMid:21068083

Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med. 2008;121(10 Suppl 1):S9-14. https://doi.org/10.1016/j.amjmed.2008.06.011 PMid:18926169 PMCid:PMC2858687

Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303-7. https://doi.org/10.1161/01.CIR.0000054612.26458.B2 PMid:12628952

Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30(1):36-40. PMid:12508387

Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11(7):390-400. https://doi.org/10.1038/nrrheum.2015.40 PMid:25825281

Navarro-MillÃ¡n I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, et al.Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. 2016;75(2):341-7. https://doi.org/10.1136/annrheumdis-2013-204987 PMid:25609412 PMCid:PMC4752663

Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford). 2014;53(12):2143-54. https://doi.org/10.1093/rheumatology/keu224 PMid:24907149 PMCid:PMC4241890

Manavathongchai S, Bian A, Rho YH, Oeser A, Solus JF, Gebretsadik T, et al. Inflammation and hypertension in rheumatoid arthritis. J Rheumatol. 2013;40(11):1806. https://doi.org/10.3899/jrheum.130394 PMid:23996293 PMCid:PMC3818311

Innala L, MÃ¶ller B, Ljung L, Magnusson S, Smedby T, SÃ¶dergren A, al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011;13(4):R131. https://doi.org/10.1186/ar3442 PMid:21843325 PMCid:PMC3239373

Grossman E, Messerli FH. Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med. 2012;125(1):14-22. https://doi.org/10.1016/j.amjmed.2011.05.024 PMid:22195528

van den Oever IA, van Sijl AM, Nurmohamed MT. Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis. 2013;5(4):166-81. https://doi.org/10.1177/1759720X13491025 PMid:23904862 PMCid:PMC3728982

Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, et al. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev. 2015;14(10):952-69 https://doi.org/10.1016/j.autrev.2015.06.004 PMid:26117596

Mjaavatten MD, Bykerk VPE. Early rheumatoid arthritis: the performance of the 2010 ACR/EULAR criteria for diagnosing RA. Best Pract Res Clin Rheumatol. 2013;27(4):451-66. https://doi.org/10.1016/j.berh.2013.09.001 PMid:24315048

MÃ¤kinen H, Kautiainen H, Hannonen P, MÃ¶ttÃ¶nen T, Korpela M, Leirisalo-Repo M, et al. Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis. Rheumatol. 2007;34(10):1987-91.

Innala L, SjÃ¶berg C, MÃ¶ller B, Ljung L, Smedby T, SÃ¶dergren A, et al. Co-morbidity in patients with early rheumatoid arthritis - inflammation matters. Arthritis Res Ther. 2016; 28:18:33.

Serelis J, Panagiotakos DB, Mavrommati M, Skopouli FN. Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a Greek cohort study. J Rheumatol. 2011;38(2):236-41. https://doi.org/10.3899/jrheum.100564 PMid:21078723

Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford). 2007;46(9):1477-82. https://doi.org/10.1093/rheumatology/kem169 PMid:17704521

Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, Kitas GD. Hypertension in rheumatoid arthritis.Rheumatology (Oxford). 2008;47(9):1286-98. https://doi.org/10.1093/rheumatology/ken159 PMid:18467370

Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66(1):28-33. https://doi.org/10.1136/ard.2006.053488 PMid:16793841 PMCid:PMC1798406

Karakoc M, Batmaz I, Sariyildiz MA, Tahtasiz M, Cevik R, Tekbas E, et al. The relationship of metabolic syndrome with disease activity and the functional status in patients with rheumatoid arthritis. J Clin Med Res. 2012;4(4):279-85. https://doi.org/10.4021/jocmr1001w

Hamamoto K, Yamada S, Yasumoto M, Yoda M, Yoda K, Tsuda A, et al. Association of Nocturnal Hypertension With Disease Activity in Rheumatoid Arthritis. Am J Hypertens. 2016;29(3):340-7. PMid:26208672

Manavathongchai S, Bian A, Rho YH, Oeser A, Solus JF, Gebretsadik T, et al. Inflammation and hypertension in rheumatoid arthritis. J Rheumatol. 2013;40(11):1806-11. https://doi.org/10.3899/jrheum.130394 PMid:23996293 PMCid:PMC3818311